Weeks 24 through 40 continue at a slower but steady pace (approaching 24% cumulative)
Timing your meals strategicallywaiting 30 to 45 minutes after your injection before eatinggives the medication time to distribute through your system before interacting with food
however, larger reductions in eGFR and less decreased LDL cholesterol levels during 1 year of followup, compared with firstline metformin initiation
Management of fatigue in patients taking GLP-1 receptor agonists begins with thorough assessment to identify contributing factors and exclude serious underlying conditions
For eligible adults with clinically significant obesity, MHRA-approved options include semaglutide (Wegovy, assessed in NICE TA875) and tirzepatide (Mounjaro, assessed in NICE TA1026), both available through NHS pathways with appropriate clinical oversight
To find the lowest effective dose for maintaining their achieved target weight, we gradually decrease the dose and reduce the frequency of dosing, she told Healthline